4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Sepsis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benowitz, NL; Bernard, GR; Calfee, CS; Havel, C; Jacob, P; Janz, DR; Kangelaris, KN; Matthay, MA; May, AK; Siew, ED; Ware, LB | 1 |
1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Sepsis
Article | Year |
---|---|
Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.
Topics: Adult; Aged; Alcoholism; APACHE; Biomarkers; Critical Illness; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Nitrosamines; Prevalence; Prospective Studies; Pyridines; Racial Groups; Respiratory Distress Syndrome; Risk Factors; Sepsis; Smoking; Tertiary Care Centers; Time Factors; Tobacco Smoke Pollution | 2015 |